127
Views
6
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Association of sedative–hypnotic medications with suicidality

, , , , &
Pages 345-349 | Published online: 09 Jan 2014

References

  • McMillan KA, Enns MW, Asmundson GJ, Sareen J. The association between income and distress, mental disorders, and suicidal ideation and attempts: findings from the collaborative psychiatric epidemiology surveys. J. Clin. Psychiatry71(9), 1168–1175 (2010).
  • Bernal M, Haro JM, Bernert S et al. Risk factors for suicidality in Europe: results from the ESEMED study. J. Affect. Disord.101(1–3), 27–34 (2007).
  • Baca-Garcia E, Perez-Rodriguez MM, Keyes KM et al. Suicidal ideation and suicide attempts in the United States: 1991–1992 and 2001–2002. Mol. Psychiatry15(3), 250–259 (2010).
  • Mentari EK, Stone M, Hammad TA. Antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch. Gen. Psychiatry67(9), 972 (2010).
  • Mitchell PB, Slade T, Andrews G. Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. Psychol. Med.34(5), 777–785 (2004).
  • El-Gabalawy R, Katz LY, Sareen J. Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom. Med.72(7), 641–647 (2010).
  • Oquendo MA, Currier D, Liu SM, Hasin DS, Grant BF, Blanco C. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J. Clin. Psychiatry71(7), 902–909 (2010).
  • Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J. Psychopharmacol.24(4 Suppl.), 81–90 (2010).
  • Bowers L, Banda T, Nijman H. Suicide inside: a systematic review of inpatient suicides. J. Nerv. Ment. Dis.198(5), 315–328 (2010).
  • Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch. Gen. Psychiatry62(3), 247–253 (2005).
  • Robson A, Scrutton F, Wilkinson L, MacLeod F. The risk of suicide in cancer patients: a review of the literature. Psychooncology19(12), 1250–1258 (2010).
  • Stenager E. [Suicidal behaviour and somatic disorders]. Ugeskr. Laeger.170(7), 517–522 (2008).
  • McLaughlin JK, Wise TN, Lipworth L. Increased risk of suicide among patients with breast implants: do the epidemiologic data support psychiatric consultation? Psychosomatics45(4), 277–280 (2004).
  • Henderson JM, Ord RA. Suicide in head and neck cancer patients. J. Oral Maxillofac. Surg.55(11), 1217–1221; discussion 1221–1212 (1997).
  • Michel K, Ballinari P, Bille-Brahe U et al. Methods used for parasuicide: results of the WHO/EURO Multicentre Study on Parasuicide. Soc. Psychiatry Psychiatr. Epidemiol.35(4), 156–163 (2000).
  • Runeson B, Tidemalm D, Dahlin M, Lichtenstein P, Langstrom N. Method of attempted suicide as predictor of subsequent successful suicide: national long term cohort study. BMJ341, c3222 (2010) (Epub ahead of print).
  • Baca-Garcia E, Diaz-Sastre C, Saiz-Ruiz J, de Leon J. How safe are psychiatric medications after a voluntary overdose? Eur. Psychiatry17(8), 466–470 (2002).
  • Novack V, Jotkowitz A, Delgado J et al. General characteristics of hospitalized patients after deliberate self-poisoning and risk factors for intensive care admission. Eur. J. Intern. Med.17(7), 485–489 (2006).
  • Youssef NA, Rich CL. Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Ann. Clin. Psychiatry20(3), 157–169 (2008).
  • Tournier M, Molimard M, Abouelfath A et al. Prognostic impact of psychoactive substances use during hospitalization for intentional drug overdose. Acta Psychiatr. Scand.112(2), 134–140 (2005).
  • Brower KJ, McCammon RJ, Wojnar M, Ilgen MA, Wojnar J, Valenstein M. Prescription sleeping pills, insomnia, and suicidality in the National Comorbidity Survey Replication. J. Clin. Psychiatry DOI: 10.4088/JCP.09m05484gry (2010) (Epub ahead of print).
  • Wojnar M, Ilgen MA, Wojnar J, McCammon RJ, Valenstein M, Brower KJ. Sleep problems and suicidality in the National Comorbidity Survey Replication. J. Psychiatr. Res.43(5), 526–531 (2009).
  • Carlsten A, Waern M. Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr.9, 20 (2009).
  • Tournier M, Grolleau A, Cougnard A, Verdoux H, Molimard M. The prognostic impact of psychotropic drugs in intentional drug overdose. Pharmacopsychiatry42(2), 51–56 (2009).
  • Leslie M, Sloan C. Poison-Related Attempted and Completed Suicides in Virginia: 2003–2006. Virginia Department of Health, VA, USA (2009).
  • Melander A, Henricson K, Stenberg P et al. Anxiolytic–hypnotic drugs: relationships between prescribing, abuse and suicide. Eur. J. Clin. Pharmacol.41(6), 525–529 (1991).
  • Hajak G, Bandelow B, Zulley J, Pittrow D. ‘As needed’ pharmacotherapy combined with stimulus control treatment in chronic insomnia – assessment of a novel intervention strategy in a primary care setting. Ann. Clin. Psychiatry14(1), 1–7 (2002).
  • Hajak G. Zolpidem ‘as needed’ versus continuous administration: Pan-European study results. Sleep Med. Rev.6(Suppl. 1), S21–S28; discussion S31–S23 (2002).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.